Intervention of isomaltodextrin mitigates intestinal inflammation in a dextran sodium sulfate-induced mouse model of colitis via inhibition of toll-like receptor-4

Kaustav Majumder, Toshihiko Fukuda, Hua Zhang, Takeo Sakurai, Yoshifumi Taniguchi, Hikaru Watanabe, Hitoshi Mitsuzumi, Toshiro Matsui, Yoshinori Mine

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Isomaltodextrin (IMD), a highly branched α-glucan, is a type of resistant starch. Earlier studies have indicated that polysaccharides could prevent inflammation and can be effective in reducing the complications of chronic gastrointestinal diseases such as inflammatory bowel disease (IBD). Therefore, the aim of the present study was to evaluate the anti-inflammatory effect of IMD in dextran sodium sulfate (DSS)-induced colitis in a mouse model. IMD (0.5, 1.0, 2.5, and 5.0% (w/v)) was given orally for 23 days to female Balb/c mice, and then 5% DSS was administered to induce colitis (from day 15 onward to the end of the trial). IMD could not prevent DSS-induced weight loss or colon shortening. However, IMD could reduce inflammatory cytokines, TNF-α and IL-6, in the colon. Gene expression indicated the tendency of IMD to suppress pro-inflammatory cytokines IL-1β, MCP-1, and IL-17 and to increase an anti-inflammatory cytokine, IL-10. Further study revealed that the antiinflammatory action of IMD mediates through inhibition of the expression of Toll-like receptor-4.

Original languageEnglish (US)
Pages (from-to)810-817
Number of pages8
JournalJournal of Agricultural and Food Chemistry
Volume65
Issue number4
DOIs
StatePublished - Feb 1 2017
Externally publishedYes

Fingerprint

Dextran Sulfate
Toll-Like Receptor 4
sodium sulfate
colitis
dextran
Colitis
cytokines
Anti-Inflammatory Agents
inflammation
animal models
Cytokines
Inflammation
colon
Colon
Glucans
Interleukin-17
resistant starch
inflammatory bowel disease
Gastrointestinal Diseases
interleukin-1

Keywords

  • Dextran sodium sulfate (DSS)-induced colitis
  • Inflammatory bowel disease
  • Inflammatory cytokine
  • Isomaltodextrin
  • Toll-like receptor-4

ASJC Scopus subject areas

  • Chemistry(all)
  • Agricultural and Biological Sciences(all)

Cite this

Intervention of isomaltodextrin mitigates intestinal inflammation in a dextran sodium sulfate-induced mouse model of colitis via inhibition of toll-like receptor-4. / Majumder, Kaustav; Fukuda, Toshihiko; Zhang, Hua; Sakurai, Takeo; Taniguchi, Yoshifumi; Watanabe, Hikaru; Mitsuzumi, Hitoshi; Matsui, Toshiro; Mine, Yoshinori.

In: Journal of Agricultural and Food Chemistry, Vol. 65, No. 4, 01.02.2017, p. 810-817.

Research output: Contribution to journalArticle

Majumder, Kaustav ; Fukuda, Toshihiko ; Zhang, Hua ; Sakurai, Takeo ; Taniguchi, Yoshifumi ; Watanabe, Hikaru ; Mitsuzumi, Hitoshi ; Matsui, Toshiro ; Mine, Yoshinori. / Intervention of isomaltodextrin mitigates intestinal inflammation in a dextran sodium sulfate-induced mouse model of colitis via inhibition of toll-like receptor-4. In: Journal of Agricultural and Food Chemistry. 2017 ; Vol. 65, No. 4. pp. 810-817.
@article{b4de59bf02c34909986b9093f294ea4d,
title = "Intervention of isomaltodextrin mitigates intestinal inflammation in a dextran sodium sulfate-induced mouse model of colitis via inhibition of toll-like receptor-4",
abstract = "Isomaltodextrin (IMD), a highly branched α-glucan, is a type of resistant starch. Earlier studies have indicated that polysaccharides could prevent inflammation and can be effective in reducing the complications of chronic gastrointestinal diseases such as inflammatory bowel disease (IBD). Therefore, the aim of the present study was to evaluate the anti-inflammatory effect of IMD in dextran sodium sulfate (DSS)-induced colitis in a mouse model. IMD (0.5, 1.0, 2.5, and 5.0{\%} (w/v)) was given orally for 23 days to female Balb/c mice, and then 5{\%} DSS was administered to induce colitis (from day 15 onward to the end of the trial). IMD could not prevent DSS-induced weight loss or colon shortening. However, IMD could reduce inflammatory cytokines, TNF-α and IL-6, in the colon. Gene expression indicated the tendency of IMD to suppress pro-inflammatory cytokines IL-1β, MCP-1, and IL-17 and to increase an anti-inflammatory cytokine, IL-10. Further study revealed that the antiinflammatory action of IMD mediates through inhibition of the expression of Toll-like receptor-4.",
keywords = "Dextran sodium sulfate (DSS)-induced colitis, Inflammatory bowel disease, Inflammatory cytokine, Isomaltodextrin, Toll-like receptor-4",
author = "Kaustav Majumder and Toshihiko Fukuda and Hua Zhang and Takeo Sakurai and Yoshifumi Taniguchi and Hikaru Watanabe and Hitoshi Mitsuzumi and Toshiro Matsui and Yoshinori Mine",
year = "2017",
month = "2",
day = "1",
doi = "10.1021/acs.jafc.6b04903",
language = "English (US)",
volume = "65",
pages = "810--817",
journal = "Journal of Agricultural and Food Chemistry",
issn = "0021-8561",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - Intervention of isomaltodextrin mitigates intestinal inflammation in a dextran sodium sulfate-induced mouse model of colitis via inhibition of toll-like receptor-4

AU - Majumder, Kaustav

AU - Fukuda, Toshihiko

AU - Zhang, Hua

AU - Sakurai, Takeo

AU - Taniguchi, Yoshifumi

AU - Watanabe, Hikaru

AU - Mitsuzumi, Hitoshi

AU - Matsui, Toshiro

AU - Mine, Yoshinori

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Isomaltodextrin (IMD), a highly branched α-glucan, is a type of resistant starch. Earlier studies have indicated that polysaccharides could prevent inflammation and can be effective in reducing the complications of chronic gastrointestinal diseases such as inflammatory bowel disease (IBD). Therefore, the aim of the present study was to evaluate the anti-inflammatory effect of IMD in dextran sodium sulfate (DSS)-induced colitis in a mouse model. IMD (0.5, 1.0, 2.5, and 5.0% (w/v)) was given orally for 23 days to female Balb/c mice, and then 5% DSS was administered to induce colitis (from day 15 onward to the end of the trial). IMD could not prevent DSS-induced weight loss or colon shortening. However, IMD could reduce inflammatory cytokines, TNF-α and IL-6, in the colon. Gene expression indicated the tendency of IMD to suppress pro-inflammatory cytokines IL-1β, MCP-1, and IL-17 and to increase an anti-inflammatory cytokine, IL-10. Further study revealed that the antiinflammatory action of IMD mediates through inhibition of the expression of Toll-like receptor-4.

AB - Isomaltodextrin (IMD), a highly branched α-glucan, is a type of resistant starch. Earlier studies have indicated that polysaccharides could prevent inflammation and can be effective in reducing the complications of chronic gastrointestinal diseases such as inflammatory bowel disease (IBD). Therefore, the aim of the present study was to evaluate the anti-inflammatory effect of IMD in dextran sodium sulfate (DSS)-induced colitis in a mouse model. IMD (0.5, 1.0, 2.5, and 5.0% (w/v)) was given orally for 23 days to female Balb/c mice, and then 5% DSS was administered to induce colitis (from day 15 onward to the end of the trial). IMD could not prevent DSS-induced weight loss or colon shortening. However, IMD could reduce inflammatory cytokines, TNF-α and IL-6, in the colon. Gene expression indicated the tendency of IMD to suppress pro-inflammatory cytokines IL-1β, MCP-1, and IL-17 and to increase an anti-inflammatory cytokine, IL-10. Further study revealed that the antiinflammatory action of IMD mediates through inhibition of the expression of Toll-like receptor-4.

KW - Dextran sodium sulfate (DSS)-induced colitis

KW - Inflammatory bowel disease

KW - Inflammatory cytokine

KW - Isomaltodextrin

KW - Toll-like receptor-4

UR - http://www.scopus.com/inward/record.url?scp=85011272772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011272772&partnerID=8YFLogxK

U2 - 10.1021/acs.jafc.6b04903

DO - 10.1021/acs.jafc.6b04903

M3 - Article

VL - 65

SP - 810

EP - 817

JO - Journal of Agricultural and Food Chemistry

JF - Journal of Agricultural and Food Chemistry

SN - 0021-8561

IS - 4

ER -